Evidence map›Paper›PMID 38468852›Full record

ArticleFrontiers in microbiology2024

Balaji Thirupathi, Yimtar Lanutoshi Pongen, Govindarajan Rasiravathanahalli Kaveriyappan, Pavan Kumar Dara, Suresh Rathinasamy, Saranya Vinayagam, Thanigaivel Sundaram, Baek Kwang Hyun, Thirumurugan Durairaj, Suresh Kumar Rajamani Sekar

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Balaji Thirupathi *Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, India.
Yimtar Lanutoshi PongenDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, India.
Govindarajan Rasiravathanahalli Kaveriyappan *Department of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk, Republic of Korea.
Pavan Kumar DaraDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, India.
Suresh RathinasamyResearch and Development Centre, Greensmed Labs, Thoraipakkam, Chennai, Tamil Nadu, India.
Saranya VinayagamDepartment of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
Thanigaivel SundaramDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, India.
Baek Kwang HyunDepartment of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk, Republic of Korea.
Thirumurugan DurairajDepartment of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, India.
Suresh Kumar Rajamani SekarCollege of Natural Sciences, SNNPR, Arba Minch University, Arba Minch, Ethiopia.
SRM Institute of Science and Technology · INYeungnam University · KRSaveetha University · INSouthern Nations, Nationalities, and Peoples' Region · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Evaluating the anticancer property of Padina boergesenii mediated bimetallic nanoparticles. Methods: The present study focuses on synthesizing Se-ZnO bimetallic nanoparticles from an aqueous algal extract of brown algae Results: The UV gave an absorbance peak at 342 and 370 nm, and the FTIR showed functional groups involved in synthesizing Se-ZnO NPs. The TEM micrographs indicated the crystalline nature and confirmed the size of the Se-ZnO NPs to be at an average size of 26.14 nm. Anticancer efficacy against the MCF-7 breast and HepG2 (hepatoblastoma) cell lines were also demonstrated, attaining an IC Discussion: This work aims to highlight an effective method for delivering bioactive compounds extracted from brown algae and emphasize its future therapeutic prospects. The potential of Selenium-Zinc oxide nanoparticles is of great interest due to the biocompatibility and low toxicity aspects of selenium combined with the cost-effectiveness and sustainability of zinc metal. The presence of bioactive compounds contributed to the stability of the nanoparticles and acted as capping properties.

Indexed as

anticancergreen synthesishepatoblastoma cell linesMCF7 breast cancer cell linePadina boergeseniiSe-ZnO nanoparticles

Identifiers

PMID38468852
PMCPMC10925794
OpenAlexW4392167231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.